IperionX Limited Sponsored ADR (NASDAQ:IPX) Stock Has Consensus Target Price of $42.00 According to Analysts

IperionX Limited Sponsored ADR (NASDAQ:IPX – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the seven ratings firms that are currently covering the company, MarketBeat reports. One equities research analyst has rated the stock with a sell rating and six have issued a buy rating on the company. The average 12-month target price among brokerages that have issued ratings on the stock in the last year is $42.00.

A number of research analysts have recently weighed in on IPX shares. B. Riley Financial cut their price objective on IperionX from $52.00 to $34.00 and set a “buy” rating on the stock in a report on Wednesday, September 30th. Jefferies Financial Group initiated coverage on IperionX in a research note on Wednesday, September 2nd. They issued a “buy” rating and a $26.00 price objective for the company. Weiss Ratings restated a “sell (e+)” rating on shares of IperionX in a research note on Friday, July 17th. Finally, Roth Capital set a $53.00 price objective on shares of IperionX in a report on Wednesday, August 5th.

Read Our Latest Research Report on IPX

IperionX Trading Up 3.1%

NASDAQ:IPX opened at $14.41 on Tuesday. IperionX has a twelve month low of $13.14 and a twelve month high of $61.45. The company’s 50 day moving average is $20.10 and its two-hundred day moving average is $27.08. The company has a debt-to-equity ratio of 0.04, a current ratio of 3.24 and a quick ratio of 2.95.

IperionX (NASDAQ:IPX – Get Free Report) last released its earnings results on Thursday, July 30th. The company reported ($0.50) earnings per share (EPS) for the quarter. On average, sell-side analysts expect that IperionX will post -0.13 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in the business. Private Advisor Group LLC boosted its stake in shares of IperionX by 69.9% in the first quarter. Private Advisor Group LLC now owns 63,111 shares of the company’s stock worth $1,643,000 after buying an additional 25,964 shares during the last quarter. Corigliano Investment Advisers LLC purchased a new position in shares of IperionX during the 4th quarter valued at approximately $362,000. DLD Asset Management LP purchased a new position in shares of IperionX during the 1st quarter valued at approximately $260,000. Connective Capital Management LLC purchased a new position in shares of IperionX during the 2nd quarter valued at approximately $160,000. Finally, GAMMA Investing LLC increased its holdings in IperionX by 40.3% in the second quarter. GAMMA Investing LLC now owns 1,681 shares of the company’s stock valued at $50,000 after buying an additional 483 shares in the last quarter. Hedge funds and other institutional investors own 2.76% of the company’s stock.

IperionX Company Profile

(Get Free Report)

IperionX Limited (NASDAQ: IPX) is a materials technology company focused on developing a U.S.-based, lower-carbon titanium supply chain. The company is working to produce titanium metal, powder and other titanium products for aerospace, defense, automotive, medical and other advanced manufacturing applications.

IperionX is developing its Titan Project in Tennessee, which is designed to supply titanium minerals and support domestic production of titanium products. The project is intended to integrate the processing of titanium mineral resources with downstream manufacturing, reducing reliance on overseas sources of titanium.

The company is also advancing proprietary processing technologies, including its Hydrogen Assisted Metallothermic Reduction process, which is designed to produce titanium metal and powder with lower energy requirements than conventional methods.

Recommended Stories

Analyst Recommendations for IperionX (NASDAQ:IPX)

Receive News & Ratings for IperionX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IperionX and related companies with MarketBeat.com's FREE daily email newsletter.